Peng B - Search Results

1

miR‑10a increases the cisplatin resistance of lung adenocarcinoma circulating tumor cells via targeting PIK3CA in the PI3K/Akt pathway.

Huang T, Ren K, Ding G, Yang L, Wen Y, Peng B, Wang G, Wang Z. Huang T, et al. Among authors: peng b. Oncol Rep. 2020 Jun;43(6):1906-1914. doi: 10.3892/or.2020.7547. Epub 2020 Mar 17. Oncol Rep. 2020. PMID: 32186774 Free PMC article.

2

Effects of Raloxifene on the Proliferation and Apoptosis of Human Aortic Valve Interstitial Cells.

Fu Z, Luo B, Li M, Peng B, Wang Z. Fu Z, et al. Among authors: peng b. Biomed Res Int. 2016;2016:5473204. doi: 10.1155/2016/5473204. Epub 2016 Nov 23. Biomed Res Int. 2016. PMID: 27999800 Free PMC article.

3

Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel.

Huang T, Yang L, Wang G, Ding G, Peng B, Wen Y, Wang Z. Huang T, et al. Among authors: peng b. Onco Targets Ther. 2017 Jan 18;10:439-446. doi: 10.2147/OTT.S125789. eCollection 2017. Onco Targets Ther. 2017. PMID: 28176922 Free PMC article.

4

Transcription Factor YY1 Modulates Lung Cancer Progression by Activating lncRNA-PVT1.

Huang T, Wang G, Yang L, Peng B, Wen Y, Ding G, Wang Z. Huang T, et al. Among authors: peng b. DNA Cell Biol. 2017 Nov;36(11):947-958. doi: 10.1089/dna.2017.3857. Epub 2017 Oct 3. DNA Cell Biol. 2017. PMID: 28972861

5

MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1.

Huang T, Wang G, Yang L, Peng B, Wen Y, Ding G, Wang Z. Huang T, et al. Among authors: peng b. Cancer Biomark. 2017 Dec 12;21(1):221-228. doi: 10.3233/CBM-170670. Cancer Biomark. 2017. PMID: 29060934

6

miR-142-5p regulates CD4+ T cells in human non-small cell lung cancer through PD-L1 expression via the PTEN pathway.

Wan J, Ling X, Peng B, Ding G. Wan J, et al. Among authors: peng b. Oncol Rep. 2018 Jul;40(1):272-282. doi: 10.3892/or.2018.6439. Epub 2018 May 16. Oncol Rep. 2018. PMID: 29767245 Free PMC article.

7

Independent prognostic value of HIF-1α expression in radiofrequency ablation of lung cancer.

Wan J, Ling X, Rao Z, Peng B, Ding G. Wan J, et al. Among authors: peng b. Oncol Lett. 2020 Jan;19(1):849-857. doi: 10.3892/ol.2019.11130. Epub 2019 Nov 21. Oncol Lett. 2020. PMID: 31897199 Free PMC article.

8

Upregulated lncRNA H19 promotes non-small cell lung cancer cell proliferation through miR-138/PDK1 axis.

Huang T, Wen Y, Peng B, Ding G, Yang L, Wang Z. Huang T, et al. Among authors: peng b. Int J Clin Exp Pathol. 2017 Aug 1;10(8):9012-9020. eCollection 2017. Int J Clin Exp Pathol. 2017. PMID: 31966771 Free PMC article.

9

Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma.

Li G, Wang G, Guo Y, Li S, Zhang Y, Li J, Peng B. Li G, et al. Among authors: peng b. World J Surg Oncol. 2020 Sep 19;18(1):249. doi: 10.1186/s12957-020-02025-0. World J Surg Oncol. 2020. PMID: 32950055 Free PMC article.

10

Thermal treatment decreases resistance to osimertinib in non-small cell lung cancer through the EGFR/PI3K/AKT pathway.

Wang J, Ling X, Zhou M, Ding G, Peng B, Wan J. Wang J, et al. Among authors: peng b. Neoplasma. 2021 May;68(3):535-545. doi: 10.4149/neo_2021_200506N489. Epub 2021 Mar 17. Neoplasma. 2021. PMID: 33724860

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,279 results

Search Page

Filters